Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

MY BOLD PREDICTION As we sit and speculate 26 h

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155128
(Total Views: 1724)
Posted On: 07/02/2020 11:10:23 AM
Posted By: CDiddy
MY BOLD PREDICTION

As we sit and speculate 26 hours a day (speaking for myself), Nader and team are confidently calm. NP's statement via email last night spoke volumes to me. "the MOA of Leronlimab the world needs. If other drugs can help then God bless them."

Dr. Lelezari and Dr. Patterson have also been extraordinarily confident.

Many of us are wondering if they know something, or if they are just getting ahead of themselves. The issue is that most of us are looking at Leronlimab through the prism of traditional medicine. (ie you take a chemical and it has a reaction in the body that helps, but also causes some other issues. This chemical reaction varies from person to person and thus the only way to determine efficacy is to test it on many people)

AFTER YOU READ THIS NEXT PART THINK BACK, OR GO RE-WATCH THE ARTICLES AND VIDEOS DESCRIBING THE MOA IN CANCER AND COVID:
Leronlimab is different. It flips a switch on the CCR5 receptor. This is not something that varies from person to person. It TURNS OFF the signaling of the CCL5 to the CCR5 receptor. This is why (albeit early) we are seeing the elimination of circulating tumor cells in the cancer patient. (not a reduction, not in some people. COMPLETE elimination)

My bold prediction, is that over time the evidence will show that Leronlimab ELIMINATES the cytokine storm. If taken at the onset, I believe it will have 100% efficacy against the virus. We will see deaths in the critical group, because they received Leronlimab too late. Some of them will die with 0 viral load. I believe that patients that receive Leronlimab early will all recover.

I recognize this is quite bold, and some will disagree. Time will tell if this is true.


(25)
(1)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us